CLOVER HEALTH INVESTMENTS, CORP. /DE
Close on Oct 19, 2026
- Market cap
- $2.42B
- P/E (TTM)
- –
- Dividend yield
- –
About Clover Health Investments
Hospital & Medical Service Plans, SIC 6324
Clover Health operates as a healthcare technology and insurance company focused on empowering physicians with proprietary software to detect, manage, and treat chronic conditions. Its primary insurance offerings include Medicare Advantage Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans, alongside specialized programs like Clover Home Care for complex patients. The company also offers Counterpart Assistant, a clinician-centric software-as-a-service and technology-enabled platform licensed to external payors and providers. Clover Health primarily serves Medicare-eligible beneficiaries, particularly seniors with chronic diseases and individuals residing in historically underserved communities.
As of January 1, 2026, the company operates its Medicare Advantage plans across five states and 203 counties. As of December 31, 2025, Clover Health employs 724 individuals located primarily in the United States and Hong Kong. Operating under a remote-first organizational model, Clover Health does not maintain a corporate headquarters.
Summary of the business section of Clover Health Investments's latest annual report, written by StockData.
Company profile
Company
- Legal name
- CLOVER HEALTH INVESTMENTS, CORP. /DE
- Founded
- 2019
- Headquarters
- Jersey City, NJ
- Address
- 30 Montgomery Street 07302
- Phone
- (201) 432-2133
- Website
- cloverhealth.com
- Employees
- 724, Dec 31, 2025
- Industry
- Hospital & Medical Service Plans
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, New York, New York
Stock & identifiers
- Ticker
- CLOV
- Exchange
- Nasdaq
- IPO date
- Apr 23, 2020
- Shares outstanding
- 531M, Jul 31, 2026
- Public float
- $1.13B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 19-for-3, May 17, 2021
- SEC CIK
- 1801170
- CUSIP
- 18914F103
- ISIN
- US18914F1030
- LEI
- 5493000HLYOYQU6LK133
- EIN
- 98-1515192
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Andrew Toy | Chief Executive Officer, Director | 9,459,316 |
| Jamie L. Reynoso | CEO, Medicare Advantage | 2,803,446 |
| Joseph Frank Oldakowski | VP OF FINANCE AND CONTROLLER | 275,897 |
| Conrad Wai | CEO, Counterpart Health | 2,235,755 |
| Karen Soares | Chief Legal Officer | 1,607,371 |
| Joseph Clay Thornton | Interim CFO | 1,249,526 |
| Brady Patrick Priest | CEO of Clover Care Services | 2,040,222 |
| Peter J. Kuipers | Chief Financial Officer | 5,758,353 |
| Carladenise Armbrister Edwards | Director | 285,432 |
| Vivek Garipalli | Director | 95,687,832 |
| Anna U. Loengard | Director | 584,666 |
| William G. Robinson Jr | Director | 597,987 |
| Thomas L. Tran | Director | 180,029 |
| Demetrios L. Kouzoukas | Director | 605,980 |
| Lee Shapiro | Director | 598,622 |
| Chelsea Clinton | Director | 602,814 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Andrew Toy | $1.32M | -$3.08M | $1.48M | $15 | $96 |
| FY2024 Andrew Toy | $9.48M | $23.94M | $3.29M | $20 | $78 |
| FY2023 Andrew Toy | $10.15M | $10.67M | $1.68M | $6 | $79 |
| FY2022 Andrew Toy | $0 | -$39.38M | $9.28M | $6 | $74 |
| FY2021 Andrew Toy | $389.57M | $62.37M | $37.03M | $23 | $93 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“At December 31, 2025, we had 724 employees with approximately 93% in the U.S.”
Corporate history
Events identified from SEC filings